automated-news
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Lowered by Stifel Nicolaus
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was downgraded by analysts at Stifel Nicolaus from a “buy” rating to a “hold” rating in a research note issued to investors on Monday, MarketBeat Ratings reports. They presently have a $13.00 price o… Read Full Article →